All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

GHK-Cu and MT-2 peptide claims: what the science actually shows

Yungkoi

TikTok creator

15.0K viewsWatch on TikTok→

Quick answer

The creator is self-administering injectable Melanotan II (MT-2) approximately once weekly for cosmetic tanning and has restarted topical or injectable GHK-Cu after pausing due to a skin reaction they describe as purging. Both compounds are being sourced from an unregulated research chemical supplier in Australia without any mention of medical supervision, vial sterility verification, or baseline dermatological assessment prior to using a melanocortin receptor agonist.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @whoisyungkoi actually say?

The creator paused their peptide routine before an event because they noticed skin "purging" from GHK-Cu use. They then restarted GHK-Cu and continued with MT-2 (Melanotan II), saying they took "about three injections over the past two, three weeks" and are "really happy with the colour." They also mention reconstituting their own vials and using a discount code for a supplier called Elite Research Australia.

There are several threads worth pulling here: the skin purging claim, the tanning results, the injection frequency, and the part where they're sourcing these compounds from a research chemical supplier and self-administering without mentioning any medical supervision whatsoever.

Does the science back this up?

On MT-2 producing a tan, yes, the basic mechanism checks out. On GHK-Cu causing skin purging, the evidence is thin. On the safety picture they're painting, it is incomplete in ways that matter.

Melanotan II is a synthetic analog of alpha-melanocyte-stimulating hormone. It binds melanocortin receptors (MC1R through MC4R) and does stimulate melanogenesis, producing pigmentation without UV exposure. That mechanism is real and documented. A 2000 study by Hadley et al. in the Journal of Endocrinology confirmed dose-dependent tanning responses in human trials. However, the same receptor activation that produces a tan also produces nausea, facial flushing, spontaneous erections, and potentially stimulates pre-existing nevi (moles), which is not a minor footnote. The World Health Organization and multiple regulatory bodies have not approved MT-2 for any indication. Calling getting "to my summer colour" the only outcome is a selective read of the evidence.

GHK-Cu (copper tripeptide-1) does have legitimate dermal research behind it. Pickart and Margolina (2018, Biomolecules) reviewed its role in wound healing and collagen synthesis. Skin purging as a concept has a mechanistic basis with retinoids and exfoliating acids. Whether GHK-Cu causes something similar is not supported by peer-reviewed data, and framing it that way could give viewers a false reason to push through adverse reactions.

What did they get wrong (or right)?

Credit where it is due: the creator got the basic tanning effect of MT-2 right, and pausing a cosmetic peptide before a public event because of a skin reaction is actually sensible behavior. They did not claim these are medical treatments or that they cure anything.

What they got wrong, or at minimum glossed over, is significant. First, "purging" with GHK-Cu is not an established clinical phenomenon. Purging is a term borrowed from retinoid use and it does not automatically transfer to a copper peptide with a different mechanism of action. If your skin is reacting badly, that is a reaction worth investigating, not labeling and waiting out.

Second, sourcing MT-2 from a "research" supplier and self-injecting is not a cosmetic routine. MT-2 is classified as a research chemical in Australia, meaning it has not cleared the regulatory bar for human use. "Research Australia" in the supplier name does not make it pharmaceutical grade. Purity, sterility, and dosing accuracy are all unknowns with unregulated suppliers. Third, no mention of baseline mole mapping before using a melanocortin agonist is a real omission given published concerns about MT-2 and nevi changes.

What should you actually know?

These two peptides sit at very different points on the risk-evidence spectrum, and conflating them in a casual "peptide journey" video obscures that.

GHK-Cu has a reasonable evidence base for topical dermal applications. Pickart et al. have published extensively on its wound-healing and anti-inflammatory properties. The risks of topical GHK-Cu are considered low. The risks of injectable GHK-Cu are far less studied in humans, and the "purging" narrative is not backed by data.

MT-2 is in a different category. A 2016 review by Cooke et al. in the British Journal of Dermatology flagged case reports of MT-2-associated changes in melanocytic nevi, including atypical features. Nausea, blood pressure fluctuation, and hyperpigmentation of existing lesions are documented adverse effects. Anyone using MT-2 without a physician supervising and without baseline dermatological assessment is taking on risks this video does not mention.

Buying peptides through a discount code from a social media creator, regardless of how good their tan looks, is not the same as obtaining a clinically supervised prescription. Reconstituting your own vials adds another layer of sterility risk that deserves more than a "let me know if you want a video on that."

Bottom line

The tanning mechanism is real. The risk picture is incomplete. If you are considering either of these compounds, a conversation with a licensed prescriber who can assess your skin, your moles, and your health history is the step this video skips entirely.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksGHK-Cu (Copper Peptide)Provider discussion

Evidence signal

Source-backed review

Regulatory reality

GHK-Cu (Copper Peptide) access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 7 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For GHK-Cu and MT-2 peptide claims: what the science actually shows, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

GHK-Cu (Copper Peptide) should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

Use the health tools and supporting evidence to prepare questions for your clinician.

Claim path

Keep researching this ghk-cu video claims cluster

Best for searchers checking whether GHK-Cu beauty and recovery claims match the evidence base.

Claim verdict

The useful answer behind this video

Claim being checked

The creator is self-administering injectable Melanotan II (MT-2) approximately once weekly for cosmetic tanning and has restarted topical or injectable GHK-Cu after pausing due to a skin reaction they describe as purging.

FormBlends verdict

The creator is self-administering injectable Melanotan II (MT-2) approximately once weekly for cosmetic tanning and has restarted topical or injectable GHK-Cu after pausing due to a skin reaction they describe as purging. Both compounds are being sourced from an unregulated research chemical supplier in Australia without any mention of medical supervision, vial sterility verification, or baseline dermatological assessment prior to using a melanocortin receptor agonist.

Patient-safe next step

Compare the claim with the GHK-Cu (Copper Peptide) guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator is self-administering injectable Melanotan II (MT-2) approximately once weekly for cosmetic tanning and has restarted topical or injectable GHK-Cu after pausing due to a skin reaction they describe as purging. Both compounds are being sourced from an unregulated research chemical supplier in Australia without any mention of medical supervision, vial sterility verification, or baseline dermatological assessment prior to using a melanocortin receptor agonist.
  • Melanotan II is not approved for human use by the TGA in Australia or the FDA in the US. Sourcing it from a research chemical supplier means purity, sterility, and potency are unverified.
  • Cooke et al. (2016, British Journal of Dermatology) documented case reports of atypical changes in melanocytic nevi associated with MT-2 use. Baseline mole mapping before using any melanocortin agonist is a clinically relevant precaution this video omits.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • GHK-Cu (Copper Peptide) decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the GHK-Cu (Copper Peptide) guide, cost path, safety notes, and provider review before acting.

Review GHK-Cu (Copper Peptide)

What You'll Learn

  • Melanotan II is not approved for human use by the TGA in Australia or the FDA in the US. Sourcing it from a research chemical supplier means purity, sterility, and potency are unverified.
  • Cooke et al. (2016, British Journal of Dermatology) documented case reports of atypical changes in melanocytic nevi associated with MT-2 use. Baseline mole mapping before using any melanocortin agonist is a clinically relevant precaution this video omits.
  • GHK-Cu has published evidence for wound healing and collagen synthesis in topical applications (Pickart and Margolina, 2018, Biomolecules), but the concept of it causing skin purging is not supported by peer-reviewed data.
  • MT-2 activates MC1R through MC4R receptors, meaning the same mechanism that produces tanning also drives documented side effects including nausea, flushing, blood pressure changes, and spontaneous erections.
  • Self-injecting any compound reconstituted from a non-pharmaceutical source introduces sterility risks that carry real infection potential, including abscess formation and systemic infection if technique or water quality is suboptimal.
  • A discount code and a research supplier in a TikTok caption is not a medical recommendation. Peptide use involving injection should involve a licensed prescriber who can assess your individual health profile.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Yungkoi · TikTok creator

15.0K views on this video

Peptide update ✨ @Elite Research Australia DC : YUNGKOI10 #ghkcu #mt2

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Yungkoi, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.